Results for the Third Quarter 2013

Sales for the quarter ended at MNOK 44.3 (MNOK 45.0). Sales as of September ended at MNOK 138.8 (MNOK 134.0). It was a strong quarter for procedural sales in the US with the highest number…

Read more

Q1 2013 financial report

Medistim reports sales revenues of MNOK 45,5 (45,1) and operating result of MNOK 7,3 (7,6) in the first quarter of 2013. The positive development in the USA continues, with 14% growth in revenues. The General…

Read more

Record Sales in Q4 2012

Medistim delivers record sales in Q4 2012 with MNOK 49.7 (MNOK 41.3). Strong growth of 13.6% for the full year, reaching MNOK 183.8 (MNOK 161.8). Operating profit (EBIT) for the quarter was MNOK 6.1 (MNOK…

Read more